Rekoop Debuts at New York Home Fashions Week,
March 19-22
Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,”
NASDAQ:APDN) today announced its CertainT® platform, ensuring
authenticity through the entire supply chain, is featured in global
manufacturer of home textiles GHCL, Limited’s (listed on NSE and
BSE) new brand of bedding products made from recycled plastic
(rPET), Rekoop. It is the first bedding line to feature 100 percent
source verified plastic and will debut at New York Home Fashions
Week, March 19 to 22, 2018. The Rekoop bedding products will be
manufactured for the US market and are anticipated toward the end
of 2018.
Rekoop employs Applied DNA’s CertainT platform to trace and
authenticate the plastic being utilized in the line of bed sheets,
pillowcases, and shams sold in-store or online in the United
States. Reliance Industries Ltd. (RIL), India’s largest private
company, the selected fiber-manufacturing partner, is using
ecofriendly Recon® Green Gold fiber.
“We are proud to introduce Rekoop, the first fully
source-verified recycled PET bedding product line,” said Manu
Kapur, president and CEO of GHCL Home Textiles. “Applied DNA’s
CertainT platform provides customers and brands with the highest
level of trust in terms of the authenticity of their products.”
“Rekoop bedding highlights the interest brands have in offering
consumers a verifiable guarantee,” said Dr. James A. Hayward,
president and CEO of Applied DNA. “CertainT does what no other
system can do – we can tag every single fiber and verify them
through a defined and secure supply chain through systematic
sampling, testing and tracking. Momentum with retailers and
manufacturers across a variety of textiles is growing and we are
pleased to see the CertainT platform and trademark now making its
way onto retail shelves this year,” he added.
Operating its home textiles facility in Vapi, in the state of
Gujarat, India, GHCL has integrated the new CertainT verified rPET
fiber into its production process, from spinning to weaving to
finished processed fabric. One of the leading manufacturers in home
textiles in India, the plant boasts an annual production capacity
of 36 million meters of finished fabric per annum. For more
information, please visit www.rekoop.pet.
About GHCL
GHCL is a well-diversified group with footprints in Chemicals,
Textiles and Consumer Products segment. GHCL’s Textiles division is
a vertically integrated manufacturing facility with spinning,
wider-width weaving, continuous fabric processing, and cut &
sew facilities for manufacturing premium quality bed linen. GHCL is
one of India’s leading manufacturers of Home Textiles, with
in-house spinning unit having capability to manufacture multiple
varieties of 100% cotton and blended yarns at various
facilities.
GHCL is known as perennial innovators in bed linen category with
some of recent innovations in the category of ‘sheets’ which
include the PERFECT FIT, EASYSHEET, microTWILL, CELLIANT, EXL
Wrinkle Free Sheets, VERSATILE–Reversible Sheets, Soft Wash Percale
and Sustainable Fibre dyed sheets.
GHCL’s Home Textiles products are predominantly exported
worldwide to countries like United Kingdom, United States of
America, Australia, Canada, Germany and other European Union
countries as well.
About Reliance Industries
Reliance Industries (RIL) is India’s largest private sector
company, with a consolidated turnover of INR 330,180 crore ($ 50.9
billion), cash profit of INR 42,800 crore ($ 6.6 billion), and net
profit of INR 29,901 crore ($ 4.6 billion) for the year ended March
31, 2017. RIL is the first private sector company from India to
feature in Fortune’s Global 500 list of ‘World’s Largest
Corporations’ – currently ranking 203rd in terms of revenues, and
110th in terms of profits. The company stands 106th in the ‘Forbes
Global 2000’ rankings for 2017 – the top-most among Indian
companies. It ranks 10th in LinkedIn’s ‘Top Companies Where India
Wants to Work Now’ (2017). RIL’s activities span hydrocarbon
exploration and production, petroleum refining and marketing,
petrochemicals, retail and 4G digital services.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-molecular
based “CertainT®” platform can be used to identify, tag, test, and
track products, to help assure authenticity, origin, traceability,
sustainability and quality of products. SigNature® DNA
describes the core technology ingredient that is at the heart of a
family of uncopyable, security and authentication solutions such as
SigNature® T and fiberTyping®, targeted toward textiles and
apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention,
and digitalDNA®, providing powerful track-and-trace. All provide a
forensic chain of evidence, and can be used to prosecute
perpetrators. Applied DNA Sciences is also engaged in the
large-scale production of specific DNA sequences using the
polymerase chain reaction.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to our lack of significant revenues, limited
financial resources, limited market acceptance, history of net
losses, market competition and various other factors detailed from
time to time in Applied DNA’s SEC reports and filings, including
our Annual Report on Form 10-K filed on December 28, 2017 and our
subsequent quarterly report on Form 10-Q filed on February 8, 2018,
which are available at www.sec.gov. Applied DNA undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date
hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180320005033/en/
Applied DNA Sciences, Inc.investors:Sanjay Hurry,
212-838-3777shurry@lhai.comormedia:Angie Mathews,
781-639-4924angie@cgprpublicrelations.comorprogram:MeiLin
Wan, 631-240-8849meilin.wan@adnas.comorDeepika Abrol,
0120
3358180deepikaabrol@ghcl.co.inorweb: www.adnas.comtwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024